On December 30, 2021, KoBioLabs, Inc closed the transaction. The company has received KRW 2,350,000,000 in its second tranche bringing the total funds raised in the transaction to KRW 6,999,997,750.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,410 KRW | -1.45% | -0.79% | -28.18% |
1st Jan change | Capi. | |
---|---|---|
-28.18% | 58.63M | |
+18.60% | 3.16B | |
+12.50% | 1.76B | |
+12.27% | 1.57B | |
-11.54% | 1.21B | |
+21.94% | 792M | |
+6.63% | 646M | |
+41.12% | 597M | |
+43.94% | 529M | |
-4.17% | 508M |
- Stock Market
- Equities
- A330730 Stock
- News Stonebridge Ventures Inc.
- KoBioLabs, Inc announced that it has received KRW 6.99999775 billion in funding from Stonebridge Ventures Inc., Industrial Bank of Korea, Investment Arm and other investors